| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| A Kinase Anchor Proteins | 9 | 2024 | 18 | 4.370 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 10 | 2024 | 160 | 2.330 |
Why?
|
| Cell Cycle Proteins | 6 | 2024 | 645 | 2.000 |
Why?
|
| Myocardium | 18 | 2020 | 989 | 1.930 |
Why?
|
| Cyclic AMP | 4 | 2020 | 248 | 0.940 |
Why?
|
| 3',5'-Cyclic-AMP Phosphodiesterases | 1 | 2024 | 22 | 0.910 |
Why?
|
| Receptors, Adrenergic | 1 | 2024 | 29 | 0.910 |
Why?
|
| Calcium | 14 | 2024 | 1098 | 0.860 |
Why?
|
| Myocytes, Cardiac | 9 | 2024 | 621 | 0.840 |
Why?
|
| Protein Transport | 2 | 2022 | 367 | 0.820 |
Why?
|
| Spectrometry, Fluorescence | 1 | 2022 | 87 | 0.780 |
Why?
|
| Signal Transduction | 8 | 2019 | 4500 | 0.770 |
Why?
|
| Myocardial Contraction | 9 | 2013 | 260 | 0.760 |
Why?
|
| Cardiomegaly | 4 | 2016 | 134 | 0.760 |
Why?
|
| Diet, High-Fat | 2 | 2019 | 212 | 0.730 |
Why?
|
| Second Messenger Systems | 1 | 2020 | 12 | 0.710 |
Why?
|
| Drug Discovery | 1 | 2022 | 170 | 0.710 |
Why?
|
| Ventricular Function | 2 | 2020 | 92 | 0.690 |
Why?
|
| Sinoatrial Node | 1 | 2020 | 24 | 0.680 |
Why?
|
| Disease Models, Animal | 9 | 2019 | 4302 | 0.680 |
Why?
|
| Heart Diseases | 1 | 2024 | 481 | 0.650 |
Why?
|
| Plaque, Atherosclerotic | 1 | 2019 | 120 | 0.590 |
Why?
|
| Cyclic Nucleotide Phosphodiesterases, Type 4 | 2 | 2018 | 11 | 0.590 |
Why?
|
| Pericardium | 1 | 2018 | 82 | 0.580 |
Why?
|
| Hyperlipidemias | 1 | 2019 | 174 | 0.580 |
Why?
|
| Pacemaker, Artificial | 1 | 2020 | 173 | 0.580 |
Why?
|
| Troponin I | 3 | 2008 | 96 | 0.570 |
Why?
|
| Mechanical Phenomena | 1 | 2017 | 16 | 0.560 |
Why?
|
| Intracellular Space | 1 | 2017 | 48 | 0.560 |
Why?
|
| Calcinosis | 1 | 2018 | 170 | 0.550 |
Why?
|
| Aortic Diseases | 1 | 2019 | 198 | 0.550 |
Why?
|
| Heart | 6 | 2024 | 723 | 0.550 |
Why?
|
| Lipids | 1 | 2019 | 513 | 0.520 |
Why?
|
| Aorta | 1 | 2019 | 542 | 0.510 |
Why?
|
| Cardiomyopathies | 3 | 2018 | 480 | 0.500 |
Why?
|
| Atherosclerosis | 2 | 2019 | 835 | 0.480 |
Why?
|
| Heart Function Tests | 2 | 2016 | 56 | 0.470 |
Why?
|
| Membrane Proteins | 1 | 2022 | 1521 | 0.460 |
Why?
|
| Phosphorylation | 8 | 2019 | 1613 | 0.460 |
Why?
|
| Animals | 32 | 2024 | 33862 | 0.460 |
Why?
|
| Isoproterenol | 4 | 2024 | 105 | 0.440 |
Why?
|
| Receptors, Adrenergic, beta | 1 | 2013 | 58 | 0.430 |
Why?
|
| HEK293 Cells | 4 | 2022 | 738 | 0.410 |
Why?
|
| Heart Failure | 4 | 2024 | 2132 | 0.410 |
Why?
|
| Polymorphism, Single Nucleotide | 2 | 2018 | 2588 | 0.380 |
Why?
|
| Mice | 21 | 2024 | 17564 | 0.360 |
Why?
|
| Muscular Atrophy | 2 | 2021 | 74 | 0.340 |
Why?
|
| Muscle, Smooth, Vascular | 3 | 2019 | 239 | 0.330 |
Why?
|
| Stem Cells | 3 | 2020 | 702 | 0.330 |
Why?
|
| Cyclic AMP-Dependent Protein Kinase Type II | 1 | 2008 | 2 | 0.320 |
Why?
|
| Myocardial Infarction | 2 | 2016 | 1007 | 0.290 |
Why?
|
| Carrier Proteins | 6 | 2015 | 1022 | 0.270 |
Why?
|
| Cardiovascular Diseases | 1 | 2018 | 1877 | 0.250 |
Why?
|
| Mutation | 6 | 2017 | 5767 | 0.250 |
Why?
|
| Peptides | 1 | 2008 | 790 | 0.240 |
Why?
|
| Cell Differentiation | 5 | 2019 | 1917 | 0.240 |
Why?
|
| Rats | 8 | 2024 | 3668 | 0.220 |
Why?
|
| Binding Sites | 2 | 2018 | 1291 | 0.210 |
Why?
|
| Cardiomyopathy, Hypertrophic | 2 | 2001 | 152 | 0.200 |
Why?
|
| Regeneration | 1 | 2024 | 203 | 0.200 |
Why?
|
| Nanotechnology | 1 | 2022 | 48 | 0.190 |
Why?
|
| Luciferases | 1 | 2022 | 136 | 0.190 |
Why?
|
| Virus Internalization | 1 | 2022 | 54 | 0.190 |
Why?
|
| Protein Binding | 2 | 2018 | 1741 | 0.190 |
Why?
|
| Myocytes, Smooth Muscle | 2 | 2019 | 160 | 0.190 |
Why?
|
| Electrocardiography | 3 | 2018 | 958 | 0.190 |
Why?
|
| Histone Deacetylases | 1 | 2022 | 114 | 0.190 |
Why?
|
| Up-Regulation | 1 | 2024 | 862 | 0.180 |
Why?
|
| Calcium-Binding Proteins | 4 | 2018 | 325 | 0.180 |
Why?
|
| Lysine | 1 | 2022 | 198 | 0.180 |
Why?
|
| Sarcomeres | 4 | 2013 | 30 | 0.180 |
Why?
|
| Adipocytes | 1 | 2022 | 158 | 0.180 |
Why?
|
| Gene Expression Regulation | 6 | 2022 | 2531 | 0.180 |
Why?
|
| Microscopy, Fluorescence | 1 | 2022 | 330 | 0.180 |
Why?
|
| Myosin Heavy Chains | 4 | 2002 | 77 | 0.170 |
Why?
|
| Male | 16 | 2024 | 60350 | 0.170 |
Why?
|
| Mice, Knockout | 5 | 2022 | 3738 | 0.170 |
Why?
|
| Receptors, Adrenergic, beta-2 | 1 | 2020 | 84 | 0.170 |
Why?
|
| Mice, SCID | 2 | 2018 | 570 | 0.170 |
Why?
|
| Myoblasts | 1 | 2019 | 30 | 0.170 |
Why?
|
| Sterol Regulatory Element Binding Protein 2 | 1 | 2019 | 7 | 0.170 |
Why?
|
| Biological Clocks | 1 | 2019 | 28 | 0.170 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2022 | 280 | 0.170 |
Why?
|
| Hydroxymethylglutaryl CoA Reductases | 1 | 2019 | 27 | 0.170 |
Why?
|
| Myocardial Reperfusion Injury | 2 | 2011 | 146 | 0.160 |
Why?
|
| Humans | 18 | 2024 | 123292 | 0.160 |
Why?
|
| Sarcoplasmic Reticulum | 4 | 2017 | 196 | 0.160 |
Why?
|
| Neointima | 1 | 2019 | 43 | 0.160 |
Why?
|
| Actin Cytoskeleton | 2 | 2004 | 44 | 0.160 |
Why?
|
| Sequestosome-1 Protein | 1 | 2018 | 12 | 0.160 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2019 | 143 | 0.160 |
Why?
|
| Protein Kinase C | 1 | 2019 | 150 | 0.160 |
Why?
|
| Sphingomyelin Phosphodiesterase | 1 | 2018 | 41 | 0.160 |
Why?
|
| Cardiotonic Agents | 2 | 2011 | 135 | 0.150 |
Why?
|
| Echocardiography | 4 | 2018 | 1050 | 0.150 |
Why?
|
| Mice, Inbred Strains | 1 | 2018 | 312 | 0.150 |
Why?
|
| Heart Ventricles | 8 | 2015 | 763 | 0.150 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2019 | 342 | 0.150 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2019 | 175 | 0.150 |
Why?
|
| Transcriptional Activation | 1 | 2019 | 482 | 0.140 |
Why?
|
| Cytosol | 2 | 2017 | 158 | 0.140 |
Why?
|
| Excitation Contraction Coupling | 1 | 2017 | 11 | 0.140 |
Why?
|
| Mice, Mutant Strains | 4 | 2013 | 388 | 0.140 |
Why?
|
| Adrenergic beta-Agonists | 1 | 1997 | 93 | 0.140 |
Why?
|
| CRISPR-Cas Systems | 1 | 2019 | 260 | 0.140 |
Why?
|
| Muscle, Skeletal | 2 | 2021 | 941 | 0.140 |
Why?
|
| Mice, Inbred C57BL | 3 | 2022 | 4364 | 0.130 |
Why?
|
| Sarcolemma | 1 | 2016 | 24 | 0.130 |
Why?
|
| Biomechanical Phenomena | 1 | 2017 | 245 | 0.130 |
Why?
|
| Histone Chaperones | 1 | 2016 | 11 | 0.130 |
Why?
|
| Acetylcysteine | 1 | 2016 | 73 | 0.120 |
Why?
|
| Cytokinesis | 1 | 2015 | 27 | 0.120 |
Why?
|
| Autophagy | 1 | 2018 | 389 | 0.120 |
Why?
|
| MicroRNAs | 1 | 2021 | 827 | 0.120 |
Why?
|
| Stem Cell Transplantation | 1 | 2016 | 238 | 0.120 |
Why?
|
| Transcription Factors | 3 | 2024 | 2591 | 0.110 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2016 | 382 | 0.110 |
Why?
|
| Phosphoric Diester Hydrolases | 1 | 2013 | 62 | 0.110 |
Why?
|
| Cricetulus | 1 | 2013 | 97 | 0.110 |
Why?
|
| CHO Cells | 1 | 2013 | 157 | 0.110 |
Why?
|
| Substrate Specificity | 1 | 2013 | 283 | 0.100 |
Why?
|
| Cricetinae | 1 | 2013 | 410 | 0.100 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2013 | 138 | 0.100 |
Why?
|
| Phenotype | 3 | 2018 | 4225 | 0.100 |
Why?
|
| Liver | 1 | 2019 | 1743 | 0.100 |
Why?
|
| Rats, Sprague-Dawley | 3 | 2011 | 1218 | 0.100 |
Why?
|
| Enkephalin, D-Penicillamine (2,5)- | 1 | 2011 | 3 | 0.100 |
Why?
|
| Amino Acid Substitution | 1 | 2013 | 393 | 0.100 |
Why?
|
| Receptors, Calcitonin Gene-Related Peptide | 1 | 2011 | 20 | 0.100 |
Why?
|
| Propanolamines | 1 | 2011 | 31 | 0.090 |
Why?
|
| Milrinone | 1 | 2011 | 30 | 0.090 |
Why?
|
| Cell Proliferation | 4 | 2019 | 2299 | 0.090 |
Why?
|
| Gene Deletion | 1 | 2013 | 793 | 0.090 |
Why?
|
| Cells, Cultured | 4 | 2019 | 3046 | 0.080 |
Why?
|
| Muscle Fibers, Skeletal | 2 | 2021 | 97 | 0.080 |
Why?
|
| Hypertension | 1 | 1997 | 1284 | 0.080 |
Why?
|
| Acute Kidney Injury | 1 | 2016 | 615 | 0.080 |
Why?
|
| Electric Stimulation | 3 | 1998 | 316 | 0.080 |
Why?
|
| Rats, Inbred WKY | 2 | 1998 | 53 | 0.070 |
Why?
|
| Rats, Inbred SHR | 2 | 1998 | 64 | 0.070 |
Why?
|
| Acute Disease | 1 | 2011 | 1093 | 0.070 |
Why?
|
| Transduction, Genetic | 1 | 2008 | 289 | 0.070 |
Why?
|
| Analgesics, Opioid | 1 | 2011 | 403 | 0.070 |
Why?
|
| Transcriptome | 3 | 2019 | 903 | 0.070 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2016 | 1098 | 0.070 |
Why?
|
| Stroke Volume | 1 | 2008 | 447 | 0.070 |
Why?
|
| Ryanodine Receptor Calcium Release Channel | 1 | 2008 | 233 | 0.070 |
Why?
|
| Adenoviridae | 1 | 2008 | 604 | 0.060 |
Why?
|
| RNA, Messenger | 3 | 2019 | 2817 | 0.060 |
Why?
|
| Serum Response Factor | 1 | 2024 | 30 | 0.060 |
Why?
|
| Postoperative Complications | 1 | 2016 | 3019 | 0.060 |
Why?
|
| Gene Expression | 1 | 2008 | 1567 | 0.060 |
Why?
|
| Blotting, Northern | 2 | 2001 | 259 | 0.060 |
Why?
|
| Ventricular Myosins | 1 | 2002 | 4 | 0.050 |
Why?
|
| Cardiomyopathy, Hypertrophic, Familial | 1 | 2002 | 4 | 0.050 |
Why?
|
| Diltiazem | 1 | 2002 | 13 | 0.050 |
Why?
|
| Acylation | 1 | 2022 | 16 | 0.050 |
Why?
|
| 3T3-L1 Cells | 1 | 2022 | 56 | 0.050 |
Why?
|
| Calcium Channel Blockers | 1 | 2002 | 113 | 0.050 |
Why?
|
| Peptide Initiation Factors | 1 | 2021 | 30 | 0.050 |
Why?
|
| Anesthetics, Intravenous | 1 | 2001 | 47 | 0.050 |
Why?
|
| Propofol | 1 | 2001 | 44 | 0.050 |
Why?
|
| Atrial Natriuretic Factor | 1 | 2001 | 52 | 0.050 |
Why?
|
| Electrophysiology | 1 | 2001 | 269 | 0.040 |
Why?
|
| Female | 3 | 2024 | 65634 | 0.040 |
Why?
|
| Family Health | 1 | 2001 | 259 | 0.040 |
Why?
|
| Sequence Homology | 1 | 2019 | 62 | 0.040 |
Why?
|
| Mutation, Missense | 2 | 2002 | 851 | 0.040 |
Why?
|
| Transgenes | 1 | 2001 | 335 | 0.040 |
Why?
|
| RNA Splicing | 1 | 2001 | 224 | 0.040 |
Why?
|
| Connexins | 1 | 2019 | 59 | 0.040 |
Why?
|
| Electrophysiological Phenomena | 1 | 2019 | 67 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-sis | 1 | 2018 | 19 | 0.040 |
Why?
|
| Actins | 1 | 2001 | 341 | 0.040 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2019 | 458 | 0.040 |
Why?
|
| Protein Isoforms | 1 | 2019 | 409 | 0.040 |
Why?
|
| Enzyme Inhibitors | 2 | 2000 | 576 | 0.040 |
Why?
|
| Myofibroblasts | 1 | 2018 | 75 | 0.040 |
Why?
|
| Actomyosin | 1 | 1998 | 7 | 0.040 |
Why?
|
| Dexamethasone | 1 | 2019 | 275 | 0.040 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2001 | 460 | 0.040 |
Why?
|
| 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester | 1 | 1997 | 6 | 0.040 |
Why?
|
| Marine Toxins | 1 | 1997 | 7 | 0.040 |
Why?
|
| 1-Methyl-3-isobutylxanthine | 1 | 1997 | 15 | 0.040 |
Why?
|
| Prazosin | 1 | 1997 | 14 | 0.040 |
Why?
|
| 8-Bromo Cyclic Adenosine Monophosphate | 1 | 1997 | 24 | 0.040 |
Why?
|
| Myosin Light Chains | 1 | 1997 | 14 | 0.040 |
Why?
|
| Colforsin | 1 | 1997 | 48 | 0.040 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2001 | 360 | 0.040 |
Why?
|
| Oxazoles | 1 | 1997 | 23 | 0.040 |
Why?
|
| Phosphates | 1 | 1998 | 111 | 0.040 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2019 | 507 | 0.040 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2019 | 280 | 0.040 |
Why?
|
| Norepinephrine | 1 | 1997 | 174 | 0.030 |
Why?
|
| Apoptosis | 2 | 2016 | 1787 | 0.030 |
Why?
|
| Adenosine Triphosphatases | 1 | 1998 | 208 | 0.030 |
Why?
|
| Wnt3A Protein | 1 | 2016 | 12 | 0.030 |
Why?
|
| Phosphoprotein Phosphatases | 1 | 1997 | 114 | 0.030 |
Why?
|
| Phosphoproteins | 1 | 2018 | 400 | 0.030 |
Why?
|
| Receptors, Purinergic | 1 | 1996 | 16 | 0.030 |
Why?
|
| Bone Morphogenetic Protein 4 | 1 | 2016 | 37 | 0.030 |
Why?
|
| Mouse Embryonic Stem Cells | 1 | 2016 | 36 | 0.030 |
Why?
|
| Renal Agents | 1 | 2016 | 5 | 0.030 |
Why?
|
| Bone Morphogenetic Protein 2 | 1 | 2016 | 84 | 0.030 |
Why?
|
| Alleles | 1 | 2001 | 1601 | 0.030 |
Why?
|
| Mesoderm | 1 | 2016 | 111 | 0.030 |
Why?
|
| Free Radical Scavengers | 1 | 2016 | 49 | 0.030 |
Why?
|
| Cell Movement | 1 | 2019 | 833 | 0.030 |
Why?
|
| Aurora Kinases | 1 | 2015 | 31 | 0.030 |
Why?
|
| Organ Specificity | 1 | 2016 | 422 | 0.030 |
Why?
|
| Base Sequence | 1 | 2019 | 3090 | 0.030 |
Why?
|
| Cell Count | 1 | 2015 | 251 | 0.030 |
Why?
|
| Treatment Failure | 1 | 2016 | 335 | 0.030 |
Why?
|
| Heart Rate | 2 | 2011 | 588 | 0.030 |
Why?
|
| Coronary Vessels | 1 | 2018 | 528 | 0.030 |
Why?
|
| Cell Lineage | 1 | 2016 | 341 | 0.030 |
Why?
|
| Indoles | 1 | 2015 | 181 | 0.030 |
Why?
|
| Dependovirus | 1 | 2015 | 129 | 0.030 |
Why?
|
| Phospholipases A | 1 | 1994 | 39 | 0.030 |
Why?
|
| Stress, Physiological | 1 | 2016 | 258 | 0.030 |
Why?
|
| Myofibrils | 2 | 2004 | 27 | 0.030 |
Why?
|
| RNA, Small Interfering | 1 | 2015 | 667 | 0.030 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2016 | 1014 | 0.030 |
Why?
|
| DNA Damage | 1 | 2016 | 513 | 0.030 |
Why?
|
| DNA Repair | 1 | 2016 | 579 | 0.030 |
Why?
|
| Fetus | 1 | 2016 | 575 | 0.020 |
Why?
|
| Receptors, Opioid, delta | 1 | 2011 | 12 | 0.020 |
Why?
|
| Endothelial Cells | 1 | 2015 | 526 | 0.020 |
Why?
|
| Animals, Newborn | 1 | 2015 | 1002 | 0.020 |
Why?
|
| Histones | 1 | 2015 | 528 | 0.020 |
Why?
|
| Neutrophils | 1 | 1994 | 373 | 0.020 |
Why?
|
| Phosphodiesterase 3 Inhibitors | 1 | 2011 | 7 | 0.020 |
Why?
|
| Adrenergic beta-1 Receptor Antagonists | 1 | 2011 | 13 | 0.020 |
Why?
|
| In Vitro Techniques | 2 | 2004 | 968 | 0.020 |
Why?
|
| Microscopy, Electron | 2 | 2004 | 391 | 0.020 |
Why?
|
| Propranolol | 1 | 2011 | 128 | 0.020 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2011 | 124 | 0.020 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2016 | 1081 | 0.020 |
Why?
|
| Calcitonin Gene-Related Peptide | 1 | 2011 | 87 | 0.020 |
Why?
|
| Survival Rate | 1 | 2016 | 2005 | 0.020 |
Why?
|
| Hospital Mortality | 1 | 2016 | 1013 | 0.020 |
Why?
|
| Time Factors | 1 | 2001 | 6223 | 0.020 |
Why?
|
| Oxidative Stress | 1 | 2016 | 796 | 0.020 |
Why?
|
| Models, Biological | 1 | 2015 | 1453 | 0.020 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2011 | 233 | 0.020 |
Why?
|
| Infusions, Intravenous | 1 | 2011 | 539 | 0.020 |
Why?
|
| Prevalence | 1 | 2016 | 2409 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2016 | 2845 | 0.020 |
Why?
|
| Homozygote | 2 | 2001 | 532 | 0.020 |
Why?
|
| Calcium-Transporting ATPases | 2 | 1999 | 55 | 0.020 |
Why?
|
| Peptide Fragments | 1 | 2011 | 747 | 0.020 |
Why?
|
| Hospitalization | 1 | 2016 | 1737 | 0.020 |
Why?
|
| Biomarkers | 1 | 2015 | 2955 | 0.020 |
Why?
|
| Blood Pressure | 1 | 2011 | 1327 | 0.020 |
Why?
|
| Papillary Muscles | 1 | 2004 | 19 | 0.010 |
Why?
|
| X-Ray Diffraction | 1 | 2004 | 95 | 0.010 |
Why?
|
| Adenosine Triphosphate | 2 | 1996 | 286 | 0.010 |
Why?
|
| Mice, Transgenic | 2 | 1999 | 2399 | 0.010 |
Why?
|
| Connexin 43 | 1 | 2003 | 30 | 0.010 |
Why?
|
| Heterotrimeric GTP-Binding Proteins | 1 | 2003 | 28 | 0.010 |
Why?
|
| GTP-Binding Protein alpha Subunits, Gq-G11 | 1 | 2003 | 18 | 0.010 |
Why?
|
| Aged | 2 | 2016 | 19180 | 0.010 |
Why?
|
| Calcineurin | 1 | 2003 | 100 | 0.010 |
Why?
|
| Calsequestrin | 1 | 2002 | 12 | 0.010 |
Why?
|
| Calcium Channels, L-Type | 1 | 2002 | 53 | 0.010 |
Why?
|
| Risk Factors | 1 | 2016 | 10033 | 0.010 |
Why?
|
| Isometric Contraction | 1 | 2001 | 22 | 0.010 |
Why?
|
| Myosins | 1 | 2001 | 46 | 0.010 |
Why?
|
| Electrophysiologic Techniques, Cardiac | 1 | 2001 | 58 | 0.010 |
Why?
|
| Minoxidil | 1 | 2000 | 5 | 0.010 |
Why?
|
| Middle Aged | 2 | 2016 | 26095 | 0.010 |
Why?
|
| Heart Conduction System | 1 | 2001 | 146 | 0.010 |
Why?
|
| Calcineurin Inhibitors | 1 | 2000 | 28 | 0.010 |
Why?
|
| Tacrolimus | 1 | 2000 | 99 | 0.010 |
Why?
|
| Cyclosporine | 1 | 2000 | 146 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2016 | 12176 | 0.010 |
Why?
|
| Sequence Deletion | 1 | 2001 | 528 | 0.010 |
Why?
|
| Heterozygote | 1 | 2001 | 678 | 0.010 |
Why?
|
| Histocytochemistry | 1 | 1999 | 99 | 0.010 |
Why?
|
| DNA Primers | 1 | 1999 | 659 | 0.010 |
Why?
|
| Survival Analysis | 1 | 2000 | 1473 | 0.010 |
Why?
|
| Thapsigargin | 1 | 1996 | 22 | 0.010 |
Why?
|
| Oscillometry | 1 | 1996 | 15 | 0.010 |
Why?
|
| Thionucleotides | 1 | 1996 | 19 | 0.010 |
Why?
|
| Cell Survival | 1 | 1999 | 805 | 0.010 |
Why?
|
| Intracellular Membranes | 1 | 1996 | 63 | 0.010 |
Why?
|
| Heart Atria | 1 | 1999 | 313 | 0.010 |
Why?
|
| Osmolar Concentration | 1 | 1996 | 176 | 0.010 |
Why?
|
| Action Potentials | 1 | 1999 | 501 | 0.010 |
Why?
|
| Caffeine | 1 | 1996 | 71 | 0.010 |
Why?
|
| Bucladesine | 1 | 1994 | 19 | 0.010 |
Why?
|
| Calcimycin | 1 | 1994 | 26 | 0.010 |
Why?
|
| Aluminum Compounds | 1 | 1994 | 17 | 0.010 |
Why?
|
| Guanosine 5'-O-(3-Thiotriphosphate) | 1 | 1994 | 26 | 0.010 |
Why?
|
| Fluorides | 1 | 1994 | 18 | 0.010 |
Why?
|
| Tetradecanoylphorbol Acetate | 1 | 1994 | 68 | 0.010 |
Why?
|
| Phospholipases A2 | 1 | 1994 | 35 | 0.010 |
Why?
|
| Leukemia, Promyelocytic, Acute | 1 | 1994 | 24 | 0.010 |
Why?
|
| Arachidonic Acid | 1 | 1994 | 70 | 0.010 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 1994 | 313 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 1996 | 1690 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 1 | 1994 | 1063 | 0.010 |
Why?
|
| Kinetics | 1 | 1994 | 1317 | 0.010 |
Why?
|
| Blotting, Western | 1 | 1994 | 1102 | 0.010 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2001 | 3087 | 0.010 |
Why?
|
| Cell Line | 1 | 1994 | 2771 | 0.000 |
Why?
|